Afatin

Afatin is Afatinib, an oral ErbB family tyrosine kinase inhibitor. It is indicated for EGFR mutation-positive non-small cell lung cancer (NSCLC) and works by irreversibly inhibiting EGFR signaling pathways involved in tumor growth and survival.

Features